InsiderClue
← All stocks

Mirum Pharmaceuticals, Inc.

MIRM Net buying
CIK 0001759425 #1236 in the set updated 17 Sep 2026
Bought (120 mo)
$127.27M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$72.36M
$2.69M on a plan · $40.63M straight out of an exercise
Sold at will
$29.05M
79 of 142 sales
Net
+$54.90M
+$98.22M against sales at will

By person

34 insiders · 214 transactions
74.1×

Christopher Peetz holds 74.1 times base salary in stock. $56.02M of shares against $755.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Christopher Peetz last reported holding, valued at $98.37, the price Common Stock was last bought or sold at on the open market here, on 14 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Peetz Christopher
CHIEF EXECUTIVE OFFICER
$294.22K (6)
$25.77M (32) scheduled
−$25.48M
569,440
0.8770%
$56.02M
+51.7%
Heron Patrick J
Director
$20.35M (19)
—
+$20.35M
464,713
0.7157%
$45.71M
—
GREY MICHAEL G
Director
—
$12.40M (7) scheduled
−$12.40M
186,410
0.2871%
$18.34M
−33.7%
Howe Jolanda
SVP, GLOBAL CONTROLLER
—
$9.33M (27) scheduled
−$9.33M
616
0.0009%
$60.60K
−65.2%
Novo Holdings A/S entity
10% owner
$8.63M (1)
—
+$8.63M
2,445,147
3.77%
$240.53M
—
BARRIS PETER J
10% owner
$6.75M (1)
—
+$6.75M
4,186,243
6.45%
$411.80M
—
BASKETT FOREST
10% owner
$6.75M (1)
—
+$6.75M
1,548
0.0024%
$152.28K
—
Behbahani Ali
10% owner
$6.75M (1)
—
+$6.75M
135
0.0002%
$13.28K
—
Chang Carmen
10% owner
$6.75M (1)
—
+$6.75M
135
0.0002%
$13.28K
—
Florence Anthony A. Jr.
10% owner
$6.75M (1)
—
+$6.75M
11,732
0.0181%
$1.15M
—
Frazier Life Sciences IX, L.P.
10% owner
$6.75M (1)
—
+$6.75M
3,566,912
5.49%
$350.88M
—
Makhzoumi Mohamad
10% owner
$6.75M (1)
—
+$6.75M
11,348
0.0175%
$1.12M
—
MAKOWER JOSHUA
10% owner
$6.75M (1)
—
+$6.75M
4,186,243
6.45%
$411.80M
—
MOTT DAVID M
10% owner
$6.75M (1)
—
+$6.75M
4,186,243
6.45%
$411.80M
—
New Enterprise Associates 16, L.P. entity
10% owner
$6.75M (1)
—
+$6.75M
2,186,243
3.37%
$215.06M
—
SANDELL SCOTT D
10% owner
$6.75M (1)
—
+$6.75M
11,348
0.0175%
$1.12M
—
Sonsini Peter W.
10% owner
$6.75M (1)
—
+$6.75M
4,186,243
6.45%
$411.80M
—
Walker Paul Edward
10% owner
$6.75M (1)
—
+$6.75M
114
0.0002%
$11.21K
—
Radovich Peter
PRESIDENT AND COO
—
$3.99M (16)
−$3.99M
57,260
0.0882%
$5.63M
+1,897%
BJERKHOLT ERIC
CHIEF FINANCIAL OFFICER
$397.69K (3)
$4.29M (14)
−$3.89M
44,745
0.0689%
$4.40M
+5,996%
Ramasastry Saira
Director
—
$2.42M (13) scheduled
−$2.42M
0
0.0000%
$0.00
—
Quan Joanne
CHIEF MEDICAL OFFICER
—
$1.78M (4)
−$1.78M
18,864
0.0291%
$1.86M
+28,055%
O'Donnell Niall
Director
$4.50M (1)
$5.96M (3)
−$1.46M
1,621,118
2.50%
$159.47M
+1,197%
Flynn James E
10% owner
$4.98M (2)
$3.62M (10)
+$1.36M
1,540,190
2.37%
$151.51M
—
Vig Pamela
CHIEF SCIENTIFIC OFFICER
$17.68K (2)
$1.20M (6) scheduled
−$1.18M
27,406
0.0422%
$2.70M
—
Brege Laura
Director
$112.20K (1)
$1.26M (2) scheduled
−$1.15M
15,703
0.0242%
$1.54M
—
Fairey William
Director
—
$155.09K (1)
−$155.09K
2,500
0.0039%
$245.93K
—
Longpre Lara
CHIEF DEVELOPMENT OFFICER
$10.27K (1)
$115.69K (5)
−$105.42K
104,407
0.1608%
$10.27M
+39.1%
Clements Ian
Chief Financial Officer
$112.52K (6)
$30.31K (1)
+$82.21K
30,011
0.0462%
$2.95M
+99,937%
Fischer Laurent
Director
$69.02K (6)
—
+$69.02K
10,727
0.0165%
$1.06M
—
Tucker Edwin Jonathan
Chief Medical Officer
$49.56K (2)
$26.26K (1)
+$23.29K
45,838
0.0706%
$4.51M
+2,956%
NEA Partners 16, L.P. entity
10% owner
—
—
—
2,186,243
3.37%
$215.06M
−47.8%
Walbert Timothy P
Director
—
—
—
9,680
0.0149%
$952.22K
—
Cardon Lon
Director
—
—
—
9,680
0.0149%
$952.22K
—

Individual transactions

79
Insider
Date
Role
Action
Shares
Price
Amount
BJERKHOLT ERIC
14 Sep 2026
CHIEF FINANCIAL OFFICER
Sell
9,943
$98.37
$978.09K
Ramasastry Saira
1 Jun 2026
Director
Sell
3,977
$100.00
$397.70K
Peetz Christopher
16 Mar 2026
CHIEF EXECUTIVE OFFICER
Sell
40,985
$91.98
$3.77M
Howe Jolanda
16 Mar 2026
SVP, GLOBAL CONTROLLER
Sell
4,732
$91.98
$435.24K
Radovich Peter
16 Mar 2026
PRESIDENT AND COO
Sell
16,515
$91.98
$1.52M
Quan Joanne
16 Mar 2026
CHIEF MEDICAL OFFICER
Sell
7,287
$91.98
$670.24K
BJERKHOLT ERIC
16 Mar 2026
CHIEF FINANCIAL OFFICER
Sell
7,287
$91.98
$670.24K
Howe Jolanda
2 Feb 2026
SVP, GLOBAL CONTROLLER
Sell
968
$103.30
$100.00K
Peetz Christopher
2 Feb 2026
CHIEF EXECUTIVE OFFICER
Sell
9,108
$103.30
$940.89K
Radovich Peter
2 Feb 2026
PRESIDENT AND COO
Sell
2,631
$103.30
$271.79K
Peetz Christopher
26 Jan 2026
CHIEF EXECUTIVE OFFICER
Sell
6,831
$96.19
$657.09K
Howe Jolanda
26 Jan 2026
SVP, GLOBAL CONTROLLER
Sell
842
$96.19
$80.99K
Radovich Peter
26 Jan 2026
PRESIDENT AND COO
Sell
3,143
$96.19
$302.33K
BJERKHOLT ERIC
26 Jan 2026
CHIEF FINANCIAL OFFICER
Sell
1,053
$96.19
$101.29K
Peetz Christopher
22 Jan 2026
CHIEF EXECUTIVE OFFICER
Sell
7,098
$93.33
$662.42K
Radovich Peter
22 Jan 2026
PRESIDENT AND COO
Sell
2,382
$93.33
$222.30K
BJERKHOLT ERIC
22 Jan 2026
CHIEF FINANCIAL OFFICER
Sell
1,421
$93.33
$132.62K
Quan Joanne
22 Jan 2026
CHIEF MEDICAL OFFICER
Sell
1,822
$93.33
$170.04K
Howe Jolanda
22 Jan 2026
SVP, GLOBAL CONTROLLER
Sell
926
$93.33
$86.42K
Quan Joanne
20 Jan 2026
CHIEF MEDICAL OFFICER
Sell
6,911
$90.27
$623.85K
BJERKHOLT ERIC
12 Sep 2025
CHIEF FINANCIAL OFFICER
Sell
9,578
$76.01
$728.02K
BJERKHOLT ERIC
11 Aug 2025
CHIEF FINANCIAL OFFICER
Sell
8,000
—
no price
Fairey William
11 Jun 2025
Director
Sell
3,203
$48.42
$155.09K
Ramasastry Saira
2 Jun 2025
Director
Sell
5,703
$46.20
$263.49K
Peetz Christopher
17 Mar 2025
CHIEF EXECUTIVE OFFICER
Sell
27,279
$44.21
$1.21M
Radovich Peter
17 Mar 2025
PRESIDENT AND COO
Sell
7,879
$44.21
$348.36K
Radovich Peter
4 Mar 2025
PRESIDENT AND COO
Sell
1,169
$45.74
$53.47K
Radovich Peter
4 Mar 2025
PRESIDENT AND COO
Sell
13,681
$45.57
$623.46K
Howe Jolanda
3 Feb 2025
SVP, GLOBAL CONTROLLER
Sell
1,064
$48.22
$51.31K
Peetz Christopher
3 Feb 2025
CHIEF EXECUTIVE OFFICER
Sell
9,102
$48.22
$438.92K
Radovich Peter
3 Feb 2025
PRESIDENT AND COO
Sell
2,627
$48.22
$126.68K
Peetz Christopher
24 Jan 2025
CHIEF EXECUTIVE OFFICER
Sell
6,837
$47.92
$327.66K
Howe Jolanda
24 Jan 2025
SVP, GLOBAL CONTROLLER
Sell
902
$47.92
$43.23K
Radovich Peter
24 Jan 2025
PRESIDENT AND COO
Sell
3,177
$47.92
$152.26K
Quan Joanne
17 Jan 2025
CHIEF MEDICAL OFFICER
Sell
6,969
$45.86
$319.60K
Howe Jolanda
7 Jan 2025
SVP, GLOBAL CONTROLLER
Sell
750
$42.82
$32.11K
Peetz Christopher
7 Jan 2025
CHIEF EXECUTIVE OFFICER
Sell
7,489
$42.82
$320.64K
Radovich Peter
7 Jan 2025
PRESIDENT AND COO
Sell
1,998
$42.82
$85.54K
Howe Jolanda
2 Jul 2024
SVP, GLOBAL CONTROLLER
Sell
375
$34.00
$12.75K
Radovich Peter
25 Mar 2024
PRESIDENT AND COO
Sell
4,303
$25.80
$111.02K
Howe Jolanda
2 Feb 2024
SVP, GLOBAL CONTROLLER
Sell
735
$26.19
$19.25K
Peetz Christopher
2 Feb 2024
CHIEF EXECUTIVE OFFICER
Sell
6,013
$26.19
$157.49K
Radovich Peter
2 Feb 2024
PRESIDENT AND COO
Sell
1,790
$26.19
$46.88K
Longpre Lara
2 Feb 2024
CHIEF DEVELOPMENT OFFICER
Sell
847
$26.19
$22.18K
Vig Pamela
2 Feb 2024
CHIEF SCIENTIFIC OFFICER
Sell
1,214
$26.19
$31.80K
Howe Jolanda
8 Jan 2024
SVP, GLOBAL CONTROLLER
Sell
528
$28.04
$14.80K
Peetz Christopher
8 Jan 2024
PRESIDENT AND CEO
Sell
5,209
$28.03
$146.03K
Vig Pamela
8 Jan 2024
HEAD OF RESEARCH & DEVELOPMENT
Sell
1,408
$28.03
$39.47K
Longpre Lara
8 Jan 2024
CHIEF DEVELOPMENT OFFICER
Sell
1,019
$28.04
$28.57K
Radovich Peter
8 Jan 2024
CHIEF OPERATING OFFICER
Sell
1,408
$28.03
$39.47K
Howe Jolanda
25 Aug 2023
SVP, Global Controller
Sell
3,459
$26.23
$90.74K
Peetz Christopher
3 Jul 2023
President and CEO
Sell
5,498
$25.65
$141.01K
Howe Jolanda
3 Jul 2023
SVP, Global Controller
Sell
915
$25.65
$23.47K
Vig Pamela
3 Jul 2023
Head of Research & Development
Sell
1,425
$25.65
$36.55K
Longpre Lara
3 Jul 2023
Chief Development Officer
Sell
1,004
$25.65
$25.75K
Radovich Peter
3 Jul 2023
Chief Operating Officer
Sell
1,425
$25.65
$36.55K
Peetz Christopher
9 Jan 2023
CHIEF EXECUTIVE OFFICER
Sell
5,159
$20.62
$106.39K
Longpre Lara
9 Jan 2023
CHIEF DEVELOPMENT OFFICER
Sell
1,003
$20.62
$20.68K
Vig Pamela
9 Jan 2023
CHIEF SCIENTIFIC OFFICER
Sell
1,379
$20.62
$28.44K
Radovich Peter
9 Jan 2023
PRESIDENT AND COO
Sell
1,379
$20.62
$28.44K
O'Donnell Niall
15 Nov 2022
Director
Sell indirect
93,770
$19.69
$1.85M
O'Donnell Niall
14 Nov 2022
Director
Sell indirect
32,109
$19.60
$629.42K
O'Donnell Niall
11 Nov 2022
Director
Sell indirect
174,121
$19.99
$3.48M
Flynn James E
6 Jun 2022
10% owner
Sell indirect
6,243
$24.47
$152.77K
Flynn James E
6 Jun 2022
10% owner
Sell indirect
6,909
$24.47
$169.06K
Flynn James E
6 Jun 2022
10% owner
Sell indirect
155
$25.08
$3.89K
Flynn James E
6 Jun 2022
10% owner
Sell indirect
171
$25.08
$4.29K
Flynn James E
6 Jun 2022
10% owner
Sell indirect
11,868
$25.29
$300.14K
Flynn James E
6 Jun 2022
10% owner
Sell indirect
13,132
$25.29
$332.11K
Tucker Edwin Jonathan
1 Oct 2021
Chief Medical Officer
Sell
1,364
$19.26
$26.26K
Radovich Peter
1 Oct 2021
Chief Operating Officer
Sell
1,364
$19.26
$26.26K
Longpre Lara
1 Oct 2021
Chief Development Officer
Sell
961
$19.26
$18.51K
Clements Ian
1 Oct 2021
Chief Financial Officer
Sell
1,574
$19.26
$30.31K
Vig Pamela
1 Oct 2021
Chief Scientific Officer
Sell
1,364
$19.26
$26.26K
Peetz Christopher
1 Oct 2021
President and CEO
Sell
3,672
$19.26
$70.71K
Flynn James E
9 Jul 2021
10% owner
Sell indirect
99,325
$15.81
$1.57M
Flynn James E
7 Jul 2021
10% owner
Sell indirect
6,837
$15.87
$108.50K
Flynn James E
6 Jul 2021
10% owner
Sell indirect
49,239
$16.20
$797.43K
Flynn James E
2 Jul 2021
10% owner
Sell indirect
10,599
$17.01
$180.30K
Show all 214 transactions →

What was left out

Form 4 filings counted 310
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 7
Sales on a Rule 10b5-1 plan 15
Sales straight out of an exercise 48
Sales at will 79
Transactions with no price 2
Shares from compensation/vesting 77,764,553
Sales filed before the plan box existed 19
History held since 18 Jul 2019